Evolent Health, Inc. EVH
4.99 USD +0.19 (+3.96%)
At closeNov 12, 2026, 4:00 AM EST
5.13 +0.14 +2.81%
Pre-market · Nov 12, 4:00 AM ET
4.77 Day range 5.01
2.10 52-week range 6.26
- YTD
- +24.75%
- 1 year
- -0.99%
News
defenseworld.net Financial Review: Evolent Health (EVH) and Its Competitors Evolent Health (NYSE: EVH - Get Free Report) is one of 93 publicly-traded companies in the "Healthcare Technology" industry, but how does it compare to its rivals? We will compare Evolent Health to…
benzinga.com Why Is Humana Stock Trading Higher Tuesday? Humana (HUM) stock jumped over 3% following a new cancer care initiative and a raised 2026 earnings outlook. Read the latest updates.
benzinga.com Humana Partners With Evolent Health, American Oncology Network To Introduce New Cancel Care Model In 8 U.S. States Humana Inc., in collaboration with Evolent Health, Inc. and American Oncology Network (AON), today announced the launch of a new cancer care model designed to improve the quality, timeliness and…
seekingalpha.com Evolent Health, Inc. (EVH) Q3 2026 Earnings Call Transcript Evolent Health, Inc. ( EVH ) Q3 2026 Earnings Call November 5, 2026 8:30 AM EST Company Participants Seth Blackley - Co-Founder, CEO & Director Mario Ramos - Chief Financial Officer Conference Call…
marketbeat.com What Evolent Health (EVH) Said on Its Q3 Earnings Call Evolent Health NYSE: EVH raised the lower end of its 2026 adjusted earnings outlook after third-quarter revenue and profitability improved from the preceding quarter, helped by growth in its…
benzinga.com Oppenheimer Maintains Outperform on Evolent Health, Raises Price Target to $7 Oppenheimer analyst Michael Wiederhorn maintains Evolent Health (NYSE:EVH) with a Outperform and raises the price target from $6 to $7.
benzinga.com Needham Maintains Buy on Evolent Health, Raises Price Target to $6 Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $5 to $6.
zacks.com Evolent Health (EVH) Matches Q3 Earnings Estimates Evolent Health (EVH) came out with quarterly earnings of $0.06 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.05 per share a year ago.
zacks.com Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key…
benzinga.com Evolent Health Q3 2026 Earnings Call Transcript Evolent Health (NYSE:EVH) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…- benzinga.com Evolent Health Affirms FY2026 Sales Guidance of $2.600B-$2.700B vs $2.626B Est Evolent Health (NYSE:EVH) affirms FY2026 sales outlook from $2.600 billion-$2.700 billion to $2.600 billion-$2.700 billion vs $2.626 billion estimate.
benzinga.com Evolent Health Q3 Adj. EPS $0.06 Beats $0.05 Estimate, Sales $725.367M Beat $724.186M Estimate Evolent Health (NYSE:EVH) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.05 by 20 percent. This is a 20 percent increase over earnings of $0.05 per…
prnewswire.com Evolent Announces Third Quarter 2026 Results WASHINGTON, Nov. 5, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through…